Seegene develops technology and products in Molecular Diagnostics that allow highly reliable pathogen identification. Established in 2000 in Seoul, Korea, Seegene has released various Molecular Diagnostics products that are developed in-house using unique and proprietary detection technologies: DPO™ (Dual Priming Oligonucleotide), TOCE™ (Tagging Oligonucleotide Cleavage and Extension) and MuDT™ (Multiple Detection Temperatures). The main product lines Allplex™ and Anyplex™ II use breakthrough multiplexing PCR technologies that enable a new standard in simultaneous multi-pathogen detection delivering maximum specificity, reproducibility and sensitivity.

BioNTech® Diagnostics GmbH

BioNTech® Diagnostics GmbH develops and commercializes innovative biomarker-based in vitro diagnostics (IVD). The company mainly focusses on the development of companion diagnostics and biomarker assays to screen and diagnose cancer and other diseases with unknown etiology.


EntroGen, Inc is a US based bio-technology company developing novel genotyping assays in the area of oncology. Their mission is to offer easy-to-use and inexpensive genotyping and mutation analysis assays to the laboratories that can be run on nearly all existing Real-time PCR instruments.